ADVANZ PHARMA Revenue and Competitors
Estimated Revenue & Valuation
- ADVANZ PHARMA's estimated annual revenue is currently $153.2M per year.
- ADVANZ PHARMA's estimated revenue per employee is $201,000
Employee Data
- ADVANZ PHARMA has 762 Employees.
- ADVANZ PHARMA grew their employee count by 5% last year.
ADVANZ PHARMA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Executive Director Sales D-A-CH | Reveal Email/Phone |
2 | Head Regulatory Affairs- EU | Reveal Email/Phone |
3 | Head Regulatory Affairs RoW | Reveal Email/Phone |
4 | Head Quality | Reveal Email/Phone |
5 | VP and General Manager | Reveal Email/Phone |
6 | Head | Global IT Infrastructure | Reveal Email/Phone |
7 | Head Supply Planning | Reveal Email/Phone |
8 | Head Patents | Reveal Email/Phone |
9 | VP Business Development & Licensing | Reveal Email/Phone |
10 | Head Quality | Reveal Email/Phone |
ADVANZ PHARMA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $58.9M | 293 | 6% | N/A | N/A |
#2 | $21.1M | 105 | 5% | N/A | N/A |
#3 | $113.4M | 564 | 1% | N/A | N/A |
#4 | $20.9M | 104 | -5% | N/A | N/A |
#5 | $37M | 184 | 9% | N/A | N/A |
#6 | $45.4M | 226 | -24% | N/A | N/A |
#7 | $16.1M | N/A | N/A | N/A | |
#8 | $69.7M | 347 | 0% | N/A | N/A |
#9 | $8M | 40 | 3% | N/A | N/A |
#10 | $25.5M | 127 | 28% | N/A | N/A |
What Is ADVANZ PHARMA?
With an impressive heritage and experience in supplying over 90 countries with more than 200 medicines, ADVANZ PHARMA strives to go beyond the fulfilment of orders for our medicines, to become a trusted and respected partner to our customers, healthcare providers/systems and patients. Our customers, partners and patients value us because we go further than simply meeting their need for quality medicines. We believe in close, collaborative partnerships that build trust and inspire better solutions.
keywords:N/A
N/A
Total Funding
762
Number of Employees
$153.2M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ADVANZ PHARMA News
... Component, Investment Trend, Financial Planning and Top Key Players (Advanz Pharma, Mylan, Sun Pharma) | Foreseen Till 2029.
... ORPHAZYME A/S, Orion Pharma Ltd., KRINGLE PHARMA, INC., F. Hoffmann-La Roche Ltd., Advanz Pharmaceutical, Otsuka Pharmaceutical Co.,...
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $348.1M | 765 | 5% | N/A |
#2 | $160.9M | 766 | 5% | N/A |
#3 | $75M | 766 | 67% | N/A |
#4 | $347.3M | 768 | 2% | N/A |
#5 | $75M | 770 | 23% | N/A |